Keywords: Affymax, Omontys, Workforce reduction, Anemia, Considering options

Affymax slashes workforce following Omontys problems; evaluating options

Article | 19 March 2013

Print This

US biopharma company Affymax (Nasdaq: AFFY) says that it will reduce its workforce as part of a plan to focus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in